Covered recipient · General Payments record
LOQUINTHA D VITAL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$12,247.11
- Reported across 138 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,129.77 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $261.81 | 8 |
| Novo Nordisk AS | $259.12 | 10 |
| Inari Medical, Inc. | $166.80 | 1 |
| Lilly USA, LLC | $141.67 | 6 |
| SANOFI-AVENTIS U.S. LLC | $107.92 | 1 |
| Acerta Pharma LLC | $101.75 | 1 |
| Abbott Laboratories | $50.49 | 1 |
| Verrica Pharmaceuticals Inc. | $26.41 | 1 |
| MannKind Corporation | $13.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $50.49 | 12/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125277519 | CMS |
| Amgen Inc. | $23.04 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117363357 | CMS |
| Amgen Inc. | $9.06 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117363363 | CMS |
| Amgen Inc. | $27.29 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117363359 | CMS |
| Amgen Inc. | $27.08 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117665097 | CMS |
| Amgen Inc. | $9.72 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117363367 | CMS |
| Amgen Inc. | $10.50 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117363365 | CMS |
| Amgen Inc. | $123.72 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117363369 | CMS |
| Amgen Inc. | $31.40 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117363361 | CMS |
| AstraZeneca Pharmaceuticals LP | $101.75 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104508192 | CMS |
| Inari Medical, Inc. | $166.80 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140190266 | CMS |
| Lilly USA, LLC | $23.03 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135803984 | CMS |
| Lilly USA, LLC | $30.03 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135753573 | CMS |
| Lilly USA, LLC | $21.28 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135795802 | CMS |
| Lilly USA, LLC | $16.14 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135741520 | CMS |
| Lilly USA, LLC | $21.82 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135795800 | CMS |
| Lilly USA, LLC | $29.37 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135797726 | CMS |
| Mannkind Corporation | $13.80 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145861199 | CMS |
| Novo Nordisk Inc | $10.64 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100293928 | CMS |
| Novo Nordisk Inc | $12.51 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100558089 | CMS |
| Novo Nordisk Inc | $18.31 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100560317 | CMS |
| Novo Nordisk Inc | $15.39 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100580744 | CMS |
| Novo Nordisk Inc | $10.04 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100256332 | CMS |
| Novo Nordisk Inc | $20.51 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100537804 | CMS |
| Novo Nordisk Inc | $15.42 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100503675 | CMS |
| Novo Nordisk Inc | $116.65 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100470396 | CMS |
| Novo Nordisk Inc | $19.57 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100486229 | CMS |
| Novo Nordisk Inc | $20.08 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100635657 | CMS |
| SANOFI-AVENTIS U.S. LLC | $107.92 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139744538 | CMS |
| Verrica Pharmaceuticals Inc. | $26.41 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118396266 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.